Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
8.07
-0.42 (-4.95%)
Jul 31, 2026, 3:04 PM EDT - Market open
Solid Biosciences Market Cap
Solid Biosciences has a market cap or net worth of $794.49 million as of July 31, 2026. Its market cap has increased by 44.98% in one year.
Market Cap
794.49M
Enterprise Value
447.27M
1-Year Change
44.98%
Ranking
Category
Stock Price
$8.07
ChartMarket Cap Chart
Since January 26, 2018, Solid Biosciences's market cap has increased from $754.10M to $794.49M, an increase of 5.36%. That is a compound annual growth rate of 0.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 794.49M | 80.81% |
| Dec 31, 2025 | 439.40M | 174.97% |
| Dec 31, 2024 | 159.80M | 28.97% |
| Dec 29, 2023 | 123.90M | 205.93% |
| Dec 30, 2022 | 40.50M | -79.02% |
| Dec 31, 2021 | 193.00M | -57.88% |
| Dec 31, 2020 | 458.20M | 123.95% |
| Dec 31, 2019 | 204.60M | -78.45% |
| Dec 31, 2018 | 949.60M | 25.92% |
| Jan 26, 2018 | 754.10M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Odyssey Therapeutics | 881.91M |
| Theravance Biopharma | 873.31M |
| Arbutus Biopharma | 871.14M |
| Annexon | 863.45M |
| Omeros | 863.44M |
| Geron | 859.64M |
| Kura Oncology | 826.49M |
| DBV Technologies | 812.86M |